Carregant...

Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a)

Aims: An abundance of epidemiological evidence demonstrates that elevated lipoprotein(a) (Lp(a)) represents a significant contributing risk factor towards the development of cardiovascular disease. In particular, raised Lp(a) may play a mechanistic role in patients with refractory angina. Studies ha...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antioxidants (Basel)
Autors principals: Khan, Tina Z., Hartley, Adam, Haskard, Dorian, Caga-Anan, Mikhail, Pennell, Dudley J., Collins, Peter, Barbir, Mahmoud, Khamis, Ramzi
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7831935/
https://ncbi.nlm.nih.gov/pubmed/33477712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antiox10010132
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!